The company will list American. Depositary Shares (ADSs), each of which will represent two shares traded on the Tel Aviv Stock Exchange (TASE). The shares debuted at a premium of 16%.
The ADRs will be traded under the ticker "MZOR". Trading in the ADSs will be through the Bank of New York Mellon.
Mazor develops and sells the Renaissance surgical navigation robot for spinal procedures, and complementary products. The system is already in use at several hospital in the US and other countries.